Topics and Expertise: computational drug discovery

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the School’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

Professor

I retired from full-time service at UCSF at the end of June, 2012. However, I went on Recall status a month later to do research, which diminishes each year. I needed to finish some projects that were still funded via grants during the initial year and continue with another funded project...